Myeloid-lineage-specific membrane protein LRRC25 suppresses immunity in solid tumor and is a potential cancer immunotherapy checkpoint target
Cell Reports · 2025
DOI: 10.1016/j.celrep.2025.115631 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2025. Verfasst von Guorong Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Tianjin Key Laboratory of Inflammatory Biology, Department of Pharmacology, School of Basic Medical Science, Tianjin Medical University, Tianjin, Chi…. Hauptthemen laut MEDLINE: Membrane Proteins, Immunotherapy, Neoplasms, Myeloid Cells. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, State Key Laboratory of Experimental Hematology, Tianjin Medical University.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Tianjin Key Laboratory of Inflammatory Biology, Department of Pharmacology, School of Basic Medical Science, Tianjin Medical University, Tianjin, China; State Key Laboratory of Experimental Hematology, Tianjin Medical U…
Förderung
- National Natural Science Foundation of China
- State Key Laboratory of Experimental Hematology
- Tianjin Medical University
- Fudan University
Zitieren
APA
Zhang, G., Yu, H., Liu, J., Dong, G., & Cai, Z. (2025). Myeloid-lineage-specific membrane protein LRRC25 suppresses immunity in solid tumor and is a potential cancer immunotherapy checkpoint target. Cell Reports. https://doi.org/10.1016/j.celrep.2025.115631
Vancouver
Zhang G, Yu H, Liu J, Dong G, Cai Z. Myeloid-lineage-specific membrane protein LRRC25 suppresses immunity in solid tumor and is a potential cancer immunotherapy checkpoint target. Cell Reports. 2025. doi:10.1016/j.celrep.2025.115631
BibTeX
@article{Zhang2025,
author = {Zhang, Guorong and Yu, Hanzhi and Liu, Jingjing and Dong, Ge and Cai, Zhigang},
title = {Myeloid-lineage-specific membrane protein LRRC25 suppresses immunity in solid tumor and is a potential cancer immunotherapy checkpoint target},
journal = {Cell Reports},
year = {2025},
doi = {10.1016/j.celrep.2025.115631}
}
EUVIMED